Radiation absorbed dose efficacy of 177Lu-DOTATATE in radionuclide therapy of neuroendocrine tumors: a hybrid study of patient and simulation
{{output}}
Recent developments in targeted radiopharmaceuticals offer promising options for diagnosis and treatment by specifically targeting the overexpressed somatostatin receptors in neuroendocrine tumors (NETs). This study aims to assess the radiation absorbed dose e... ...
